HALOZYME THERAPEUTICS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Halozyme Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 169 %, a 12.8% decline year-over-year.
  • Halozyme Therapeutics, Inc. annual Return On Equity for 2023 was 205 %, a 108% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Return On Equity for 2022 was 98.6 %, a 59.2% decline from 2021.
  • Halozyme Therapeutics, Inc. annual Return On Equity for 2021 was 242 %, a 93.8% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 205 +106 +108% Jan 1, 2023 Dec 31, 2023
2022 98.6 -143 -59.2% Jan 1, 2022 Dec 31, 2022
2021 242 +117 +93.8% Jan 1, 2021 Dec 31, 2021
2020 125 +159 Jan 1, 2020 Dec 31, 2020
2019 -33.7 -1.85 -5.81% Jan 1, 2019 Dec 31, 2019
2018 -31.9 -122 -135% Jan 1, 2018 Dec 31, 2018
2017 89.8 -8.02K -98.9% Jan 1, 2017 Dec 31, 2017
2016 8.11K +8.19K Jan 1, 2016 Dec 31, 2016
2015 -79.3 +55.2 +41% Jan 1, 2015 Dec 31, 2015
2014 -135 +1.59K +92.2% Jan 1, 2014 Dec 31, 2014
2013 -1.73K -1.64K -1917% Jan 1, 2013 Dec 31, 2013
2012 -85.6 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.